m
Recent Posts
Connect with:
Wednesday / November 18.
Homeminews (Page 824)

Applications for the annual Glaucoma Australia Quinlivan Research Grants are now open and will be accepted until 5pm (AEST) 1 July 2021. Successful recipients

Expanding clinical applications make autofluorescence an essential tool for evaluating age related macular degeneration, macular dystrophies and many other retinal disorders.

The Therapeutic Goods Administration (TGA) of Australia has granted regulatory approval for the Preserflo MicroShunt. Distributed by Glaukos, the Preserflo MicroShunt is intended for

Research conducted in the United Kingdom by OCL Vision provides new insight into the attitudes of different ages groups towards their eye health. Most

DECLARATION

DISCLAIMER : THIS WEBSITE IS INTENDED FOR USE BY HEALTHCARE PROFESSIONALS ONLY.
By agreeing & continuing, you are declaring that you are a registered Healthcare professional with an appropriate registration. In order to view some areas of this website you will need to register and login.
If you are not a Healthcare professional do not continue.